PRESS RELEASE published on 08/15/2025 at 07:30, 1 year ago Informations privilégiées / Autres communiqués Sensorion augmente les moyens du contrat de liquidité avec Kepler Cheuvreux conformément à la décision de l'AMF. Détails des actions et du montant ajouté Biotechnologie Kepler Cheuvreux Liquidité AMF Sensorion
BRIEF published on 07/31/2025 at 09:22, 1 year 1 month ago Sensorion Announces Participation in Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Therapies September-October 2025
BRIEF published on 07/31/2025 at 09:22, 1 year 1 month ago Sensorion annonce sa participation à des conférences d'investisseurs Biotechnologie Conférences Investisseurs Sensorion Thérapies Auditives Septembre-Octobre 2025
PRESS RELEASE published on 07/31/2025 at 09:17, 1 year 1 month ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs à venir en septembre et octobre 2025. La société présentera ses avancées dans le domaine de la biotechnologie et des thérapies pour la perte auditive Biotechnologie Conférences Investisseurs Sensorion Perte Auditive Thérapies Auditives
BRIEF published on 07/01/2025 at 07:35, 1 year 2 months ago Sensorion Reports Positive Preliminary Data from Audiogene Phase 1/2 Trial Gene Therapy Sensorion SENS-501 Congenital Deafness Audiogene Trial
BRIEF published on 07/01/2025 at 07:35, 1 year 2 months ago Sensorion publie des données préliminaires positives issues de l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion SENS-501 Surdité Congénitale Essai Audiogene
PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 2 months ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 2 months ago Informations privilégiées / Autres communiqués Sensorion annonce des données préliminaires positives de la première cohorte de l'essai clinique de Phase 1/2 de thérapie génique Audiogene évaluant le SENS-501 pour traiter une forme spécifique de surdité congénitale Sécurité Thérapie Génique Sensorion Surdité Audiogene
BRIEF published on 05/13/2025 at 07:35, 1 year 3 months ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
BRIEF published on 05/13/2025 at 07:35, 1 year 3 months ago Sensorion annonce l'approbation des résolutions de l'assemblée générale des actionnaires Biotechnologie Thérapie Génique Sensorion Résolutions Des Actionnaires Thérapie De La Perte Auditive
Published on 09/08/2026 at 01:45, 3 hours 31 minutes ago Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 3 days 1 hour ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 5 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 6 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 6 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/07/2026 at 19:19, 9 hours 57 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 10 hours 16 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 10 hours 33 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 11 hours 16 minutes ago E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 11 hours 31 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 09/07/2026 at 19:00, 10 hours 16 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 10 hours 16 minutes ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 11 hours 11 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 11 hours 11 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
